Etidronate disodium in the management of malignancy-related hypercalcemia
- 1 February 1987
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 82 (2), 51-54
- https://doi.org/10.1016/0002-9343(87)90487-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- Comparative study of available medical therapy for hypercalcemia of malignancyAmerican Journal Of Medicine, 1983
- Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeletonAmerican Journal Of Medicine, 1983
- Disequilibrium hypercalcaemia.BMJ, 1983
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyThe American Journal of Medicine, 1982
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseasesMetabolism, 1976
- Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivoScience, 1969
- The Renal Diluting and Concentrating Mechanism in HypercalcemiaNephron, 1969